BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 239485)

  • 1. The effects of sulphydryl reagents on the binding and mixed function oxidation of hexobarbital in rat hepatic microsomes.
    Paul H; Illing A; Netter KJ
    Xenobiotica; 1975 Jan; 5(1):1-15. PubMed ID: 239485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: The role of sulphydryl groups in microsomal mixed function oxidation of drugs.
    Illing HP; Puhalla G; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R37. PubMed ID: 4276568
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 2,4-dinitrophenol on the oxidative metabolism of hexobarbital by cytochrome P-450 in perfused rat liver.
    Suzaki T; Iyanagi T; Kobayashi S
    J Biochem; 1983 Aug; 94(2):361-71. PubMed ID: 6630164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differentiation of N-oxidation and N-dealkylation of N-ethyl-N-methylaniline by rabbit liver microsomes as distinct metabolic routes.
    Gorrod JW; Temple DJ; Beckett AH
    Xenobiotica; 1975 Aug; 5(8):465-74. PubMed ID: 241156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation-reduction states of pyridine nucleotide and cytochrome P-450 during mixed-function oxidation in perfused rat liver.
    Iyanagi T; Suzaki T; Kobayashi S
    J Biol Chem; 1981 Dec; 256(24):12933-9. PubMed ID: 7309741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol.
    Hayashi N; Kamada T; Sato N; Kasahara A; Peterson JA
    Dig Dis Sci; 1985 Apr; 30(4):334-9. PubMed ID: 2983957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperonyl butoxide metabolism by cytochrome P-450: factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex.
    Franklin MR
    Xenobiotica; 1972 Nov; 2(6):517-27. PubMed ID: 4145693
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital.
    Bast A; Noordhoek J
    Biochem Pharmacol; 1980 Mar; 29(5):747-51. PubMed ID: 20227951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450.
    Babany G; Tinel M; Letteron P; Freneaux E; Berson A; Larrey D; Pessayre D
    Biochem Pharmacol; 1989 Mar; 38(6):941-7. PubMed ID: 2930595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hexobarbital-oxidation in vivo and in vitro in rats after phenobarbital-pretreatment or after portacaval anastomosis (author's transl)].
    Richter E; Gallenkamp H; Brachtel D; Grün M
    Z Gastroenterol; 1977 Jun; 15(6):389-92. PubMed ID: 888489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effect of carbon monoxide on hexobarbital metabolism in the isolated perfused liver in the absence of hemoglobin.
    Takano T; Motohashi Y; Miyazaki Y; Okeda R
    J Toxicol Environ Health; 1985; 15(6):847-54. PubMed ID: 4057285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of hexaprenyl-diphosphate synthase of Micrococcus luteus B-P 26 against inactivation by sulphydryl reagents and arginine-specific reagents.
    Yoshida I; Koyama T; Ogura K
    Biochim Biophys Acta; 1989 Apr; 995(2):138-43. PubMed ID: 2539196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enzymic formation of methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes.
    Franklin MR
    Xenobiotica; 1971 Nov; 1(6):581-91. PubMed ID: 4154538
    [No Abstract]   [Full Text] [Related]  

  • 17. Hexobarbital-binding, hydroxylation and hexobarbital-dependent hydrogen peroxide production in hepatic microsomes of guinea pig, rat and rabbit.
    Heinemeyer G; Nigam S; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):201-10. PubMed ID: 7453835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new spectral intermediate associated with cytochrome P-450 function in liver microsomes.
    Estabrook RW; Hildebrandt AG; Baron J; Netter KJ; Leibman K
    Biochem Biophys Res Commun; 1971 Jan; 42(1):132-9. PubMed ID: 4396002
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone modulation of liver drug metabolic enzyme activity in the rat. I. Effect of the hormone on the content and rate of reduction of microsomal cytochrome P-450.
    Wilson JT
    Biochem Pharmacol; 1973 Jul; 22(14):1717-28. PubMed ID: 4146051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in testosterone oxidation in rat liver microsomes after prolonged administration of ethylmorphine].
    Pospelova LN; Chistiakov VV
    Biokhimiia; 1981 Feb; 46(2):347-52. PubMed ID: 7248389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.